Protocol No. Palo-99-05 A Double-Blind Clinical Study Single IV Doses of Palonosetron, .25mg or .75mg, and Ondansetron, 32mg IV, in the Prevention of Highly Emetogenic Chemotheraphy-Induced Nausea and Vomiting IND#39,797

  • Gallion, Holly (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date10/1/0010/1/01